Incyte (INCY) Cash from Operations Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 34.32% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 76.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.49% |
| Dec 31, 2025 | 24.19% |
| Sep 30, 2025 | 23.58% |
| Jun 30, 2025 | -36.43% |
| Mar 31, 2025 | 7.24% |
| Dec 31, 2024 | 48.95% |
| Sep 30, 2024 | 6.81% |
| Jun 30, 2024 | -74.66% |
| Mar 31, 2024 | 2.02% |
| Dec 31, 2023 | 11.24% |
| Sep 30, 2023 | -6.72% |
| Jun 30, 2023 | 4.40% |
| Mar 31, 2023 | 46.34% |
| Dec 31, 2022 | 29.17% |
| Sep 30, 2022 | 3.10% |
| Jun 30, 2022 | 4.42% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | 11.22% |
| Sep 30, 2021 | 8.60% |
| Jun 30, 2021 | 74.76% |
| Mar 31, 2021 | 114.65% |
| Dec 31, 2020 | 47.40% |
| Sep 30, 2020 | 50.78% |
| Jun 30, 2020 | 32.12% |
| Mar 31, 2020 | -57.89% |
| Dec 31, 2019 | 11.72% |
| Sep 30, 2019 | 41.59% |
| Jun 30, 2019 | 105.71% |
| Mar 31, 2019 | 16.86% |
| Dec 31, 2018 | 4.78% |
| Sep 30, 2018 | 195.44% |
| Jun 30, 2018 | 34.26% |
| Mar 31, 2018 | 87.04% |
| Dec 31, 2017 | -58.69% |
| Sep 30, 2017 | 24.11% |
| Jun 30, 2017 | 115.61% |
| Mar 31, 2017 | -76.29% |
| Dec 31, 2016 | 115.97% |
| Sep 30, 2016 | 115.25% |
| Jun 30, 2016 | 29.55% |
| Mar 31, 2016 | 57.98% |
| Dec 31, 2015 | 74.48% |
| Sep 30, 2015 | 31.70% |
| Jun 30, 2015 | 15.35% |
| Mar 31, 2015 | 56.15% |
| Dec 31, 2014 | 46.19% |
| Sep 30, 2014 | 37.36% |
| Jun 30, 2014 | 22.05% |
| Mar 31, 2014 | 10.51% |
| Dec 31, 2013 | -34.38% |
| Sep 30, 2013 | 26.03% |
| Jun 30, 2013 | 70.10% |
| Mar 31, 2013 | -37.80% |